Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
UnitedHealth
UNH
|
$1.48B |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$789M |
| 3 |
Teledyne Technologies
TDY
|
$767M |
| 4 |
AMRZ
Amrize Ltd
AMRZ
|
$622M |
| 5 |
Comcast
CMCSA
|
$609M |
Top Sells
| 1 |
Williams Companies
WMB
|
$1.58B |
| 2 |
Cisco
CSCO
|
$1.46B |
| 3 |
GE Aerospace
GE
|
$1.27B |
| 4 |
UBS Group
UBS
|
$913M |
| 5 |
Capital One
COF
|
$728M |
Sector Composition
| 1 | Healthcare | 23.24% |
| 2 | Financials | 18.09% |
| 3 | Industrials | 12.75% |
| 4 | Technology | 11.73% |
| 5 | Communication Services | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Boston Scientific
BSX
$156B
| $9.71M | 0.01% | 90,385 -1,310 | -1% | -$141K |
|
127
AstraZeneca
AZN
$248B
| $9.61M | 0.01% | 137,488 +1,348 | +1% | +$94.2K |
|
128
Home Depot
HD
$405B
| $8.66M | ﹤0.01% | 23,622 +350 | +2% | +$128K |
|
129
Exxon Mobil
XOM
$487B
| $8.37M | ﹤0.01% | 77,616 -247 | -0.3% | -$26.6K |
|
130
Adobe
ADBE
$151B
| $7.6M | ﹤0.01% | 19,657 -243 | -1% | -$94K |
|
131
Analog Devices
ADI
$124B
| $7.33M | ﹤0.01% | 30,805 -280 | -0.9% | -$66.6K |
|
132
Deere & Co
DE
$129B
| $6.48M | ﹤0.01% | 12,736 | – | – |
|
133
Vulcan Materials
VMC
$38.5B
| $6.31M | ﹤0.01% | 24,200 | – | – |
|
134
Apple
AAPL
$3.45T
| $6.21M | ﹤0.01% | 30,244 +3,100 | +11% | +$636K |
|
135
Berkshire Hathaway Class B
BRK.B
$1.09T
| $6.19M | ﹤0.01% | 12,740 | – | – |
|
|
HES
136
DELISTED
Hess
HES
| $6.17M | ﹤0.01% | 44,525 -1,350 | -3% | -$187K |
|
137
Broadcom
AVGO
$1.4T
| $5.84M | ﹤0.01% | 21,180 +510 | +2% | +$141K |
|
138
Synopsys
SNPS
$112B
| $5.64M | ﹤0.01% | 11,000 -250 | -2% | -$128K |
|
139
Motorola Solutions
MSI
$78.7B
| $4.77M | ﹤0.01% | 11,355 +127 | +1% | +$53.4K |
|
140
Shell
SHEL
$215B
| $4.03M | ﹤0.01% | 57,213 -250 | -0.4% | -$17.6K |
|
141
Amgen
AMGN
$155B
| $3.82M | ﹤0.01% | 13,682 +150 | +1% | +$41.9K |
|
142
Danaher
DHR
$147B
| $3.26M | ﹤0.01% | 16,525 | – | – |
|
143
Johnson & Johnson
JNJ
$427B
| $3.2M | ﹤0.01% | 20,947 -150 | -0.7% | -$22.9K |
|
144
Philip Morris
PM
$260B
| $3.1M | ﹤0.01% | 17,000 | – | – |
|
145
Dell
DELL
$82.6B
| $3.02M | ﹤0.01% | 24,630 +278 | +1% | +$34.1K |
|
|
146
Berkshire Hathaway Class A
BRK.A
$1.09T
| $2.92M | ﹤0.01% | 4 | – | – |
|
147
S&P Global
SPGI
$167B
| $2.85M | ﹤0.01% | 5,400 | – | – |
|
|
JNPR
148
DELISTED
Juniper Networks
JNPR
| $2.67M | ﹤0.01% | 66,959 -2,616 | -4% | -$104K |
|
149
PNC Financial Services
PNC
$81.7B
| $2.62M | ﹤0.01% | 14,080 -120 | -0.8% | -$22.4K |
|
150
Pfizer
PFE
$141B
| $2.62M | ﹤0.01% | 107,960 -1,750 | -2% | -$42.4K |
|